Our proprietary SIF, LAI drug delivery technologies enables us to develop differentiated, ready-to-use, long-acting injectable products through 505 (b) (2) or 505 (b) (1) regulatory pathways.

我們的專有穩定長效注射劑型（SIF-LAI）平台技術使我們能透過 505(b)(2) 類新藥或 505(b)(1) 創新成分新藥法規途徑，開發具差異化、預充填式的長效注射產品。

Foresee's R&D efforts are focused on two key areas, namely its unique Stabilized Injectable Formulation (SIF) long-acting injectable (LAI) technology (SIF-ADAGIO, SIF-LEGATO, SIF …

© 2018 Sif Biopharma. All rights reserved. Design template from HTML5 UPHTML5 UP

Pharmaceutical Chemistry – I 75 75 25 Pharmacognosy 75 75 25 Biochemistry and Clinical Pathology 50 75 25 Human Anatomy and Physiology 75 50 25 Health Education and …

SiF pharmaceuticals. 665 likes. Sif pharmaceuticals is fastest growing company,with believe "YOUR TRUST IS OUR ASSET " regarding comunity health & our...

First Class B.Pharm with Master’s degree in Pharmacy (M.Pharm) in appropriate branch of specialization in Pharmacy or Pharm.D (Qualifications must be PCI recognized). Ph.D degree …

Il sito della SIF che, aggiornato a cadenza mensile, fornisce informazioni relative alla sicurezza dei farmaci. La Sezione della SIF che raccoglie i farmacologi attivi a livello clinico e promuove …

2024年8月9日 · 逸達生物科技股份有限公司（Foresee Pharmaceuticals Co., Ltd.）為一營運跨台美兩地，發行股票在台灣櫃買中心（Taipei Exchange）掛牌交易（TPEx：6576）之生技醫藥 …

SIF Pharma. 110 likes. Fast Growing pharmaceutical company.